No Promises to Cure COVID-19, FIR against Patanjali

Must Read

What is the Real Estate (Regulation and Development) Act, 2016?

The Real Estate (Regulation and Development) Act, 2016 (“RERA”) is an Act of the Parliament. It seeks to protect...

Should the Exorbitant Amounts Charged for RT-PCR Tests be Refunded?

Introduction A plea has been filed in the Honourable Supreme Court of India seeking a refund of exorbitant amounts charged...

Should CCTV’s be Installed in the Police Station?

Introduction In a recent judgment, the bench led by Justice Nariman issued directions to both the state and Union Territory...

A Legal Analysis of the West Bengal Political Crisis on IPS Deputation

The Ministry of Home Affairs (MHA) has recently summoned three IPS officers of West Bengal (WB). The decision was...

Explained: Postal Ballot for NRIs

At the end of November 2020, Election Commission sent a proposal to the law ministry to amend the Representation...

Explained: Constitutional Provisions and Legislations With Regards to a Person with Disabilities

The world celebrates December 3 as International Day of Persons with Disabilities (IDPD). This day is also called World...

Follow us

COVID-19, or coronavirus disease, is a contagious illness. A newly discovered coronavirus causes it. Coronaviruses are a large family of viruses causing a wide range of illnesses. They can range from the common cold to more severe ones like MERS-COV and SARS-COV. This new strain of coronavirus was first observed in Wuhan, China, in December 2019. It then spread globally and the WHO classified it as a pandemic. As of now, there are no reported effective-proven cures. But, there are on-going treatment procedures over the world. International and national health organizations have also released prevention methods.

Unproven claims of cures and vaccines around the world 

Italian firm Takis biotechs were first to claim to have created a successful COVID-19 vaccine in April 2020. It generates antibodies in mice that neutralize SARS-COV in human cells.

Oxford University co-developed an experimental vaccine with a British-Swedish multinational pharmaceutical company, AstraZeneca. They named it ChAdOx1 nCoV-19. They started its final stage of clinical trials in South Africa vaccine in June. It uses a weakened strain of a common cold virus called adenovirus.

In May, Israeli defence minister Naftali Bennett announced that their Institute for Biological Research (IIBR) has made a breakthrough. It developed a monoclonal antibody, which neutralizes the novel coronavirus.

Countries have also started convalescent plasma therapy for treatment. It involves transfusion of plasma from people who have recovered from the virus to high-risk coronavirus patients. It helps kick-start the passive immunity in the patient. Moreover this could help those whose bodies aren’t producing enough antibodies to curb the disease. Union Health Ministry has allowed its use for treatment. But, it has also said that their use is currently based on limited evidence.

Hydroxychloroquine

Hydroxychloroquine has shown antiviral properties against SARS-COV-2 through in-vitro studies. It treats malaria. Brazilian and American Presidents Jair Bolsonaro and Donald Trump have promoted it. There have been studies from China, France, and the USA testing the drug. They have both proven effectiveness and ineffectiveness of this drug.

Remdesivir

Remdesivir is a broad-spectrum antiviral treatment developed by Gilead Sciences Inc. It has shown promise in animal models for treating SARS-COV-2 infection. Remdesivir has been examined in various clinical trials. The National Institute of Health of USA conducted a randomized, controlled trial. They found that advanced COVID-19 patients who got remdesivir recovered faster than patients who got placebos. A Chinese trial found that remdesivir did not improve the condition of serious COVID-19 patients compared to placebos.

Pfizer and BioNtech (USA pharmaceutical companies) have partnered up. They are running the clinical trials of their BNT162 vaccine (an RNA vaccine) program.

Dexamethasone is an inexpensive and used steroid. The Union Health Ministry included it in the treatment protocol for COVID-19 patients for moderate to severe stages of illness by June 27.

Patanjali’s COVID cure claims and AYUSH Ministry response

On June 23, 2020, Patanjali launched ‘Coronil and Swasari’.  They marketed it as a cure for the treatment of COVID-19. Patanjali claimed to have had 100 percent favourable results in the clinical trials on affected patients. The Haridwar-based Patanjali Research Institute and the National Institute of Medical Sciences, Jaipur conducted the trials.

The Union Ministry of AYUSH ordered Patanjali to provide them with a list. It was to contain the name and composition of all the medicines in this kit, as well as the studies it conducted. Until the ministry verified these, it forbade Patanjali from advertising these claims.

Patanjali made its reply to the AYUSH ministry public. It included the composition of medicines; IEC clearance and CTRI registration; and protocol sample size and result data of the study.

Legal Action Against Coronil

The Rajasthan Health Department sent a notice to NIMS Jaipur. It sought explanation for conducting Patanjali’s Coronil clinical trials on COVID-positive patients. NIMS did not ask the state government’s permission or inform them.

On June 27, an FIR was filed in Jaipur’s Jyoti Nagar Police Station against Ramdev, Patanjali Ayurved MD Acharya Balkrishna, scientist Anurag Varshney, NIMS Chairman Dr. Balbir Singh Tomar and Director Dr Anurag Tomar. It charged them under section 420 (cheating) of the Indian Penal Code (among others). The FIR was filed for allegedly indulging in the misleading publication of “Coronil”. It was publicised as medicine which could be used to treat the COVID. 

Conclusion 

Paranoia and fear related to COVID-19 are very high at the moment. This is adding to the desperation of the public. It is making it easier for unproven claims of miracle cures and antidotes get popular. People are rushing in to use desperate means without official backing. This is only worsening the situation. 

Humanity is going through such a difficult time together. It is more important to be aware of our surroundings. Trusting people or things without proper evidence is not advisable.


Libertatem.in is now on Telegram. Follow us for regular legal updates and judgements from the court. Follow us on Google News, InstagramLinkedInFacebook & Twitter. You can also subscribe for our Weekly Email Updates. You can also contribute stories like this and help us spread awareness for a better society. Submit Your Post Now.    

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Latest News

[WhatsApp Privacy Policy Row] It’s a Private App, Don’t Use It; Says Delhi High Court

On Monday, while hearing a petition regarding the privacy policy of WhatsApp, the Delhi High Court said, “It is a private app. Don't join it. It is a voluntary thing, don't accept it. Use some other app.”

Madras High Court Asks the State To Reconsider Number of Seats Allotted for Bcm Category

Mr. Shakkiya filed a Writ Petition under Article 226 of the Indian Constitution to issue a Writ of Mandamus. The petition sought to direct...

Gujarat High Court Directs To Register Name of Petitioners in the Society Records as Owners of Property, as per Will

A single-judge bench of Gujarat High Court consisting of Honourable Justice Biren Vaishnav, because probate wasn’t necessary and that the petitioners were entitled to...

If No Complaint Is Filed, No Further Orders Are Required To Be Passed: Telangana High Court

Excerpt In Matlakunta Sundaramma vs The State Of Telangana, on January 8, 2021, the Telangana High Court decided that there is no requirement of passing...

Gujarat High Court Allows Report Filed by Official Liquidator for Dissolution of the Company

The present report had been filed by the Official Liquidator for the dissolution of M/s AtRo Limited under the provisions of Section 497 (6)...

Parents of Road Accident Victim Entitled To Compensation: Delhi High Court

Justice JR Midha said, “Even if parents are not dependent on their children at the time of an accident, they will certainly be dependent, both financially and emotionally, upon them at the later stage of their life, as the children were dependent upon their parents in their initial years.”

Plea Challenging the AIBE Rules Framed by BCI Filed in the Supreme Court

A Writ Petition was presently filed in the Supreme Court by a newly enrolled lawyer challenging the All India Bar Examination Rules 2010 which have been framed by the Bar Council of India which mandates that an advocate has to qualify for the All India Bar Examination (AIBE) to practice law after enrollment.

Bombay High Court: Mere Presence at the Crime Scene Not Enough for Punishment

The Bombay High Court ruled that it cannot be considered a crime if a person is merely present at the crime scene which falls under the Maharashtra Prohibition of Obscene Dance in Hotels and Restaurants and Bar Rooms and Protection of Dignity of Women Act 2016. It also quashed two First Information Reports (FIR) against two individuals who were arrested in a raid at a dance bar by the Santacruz Police, in 2017.

CAIT Files a Plea Against WhatsApp’s New Privacy Policy in the Supreme Court

Confederation of All India Traders (CAIT) has filed a petition against WhatsApp’s new privacy rules in the Supreme Court. The petition says that WhatsApp which is known to render public services by providing a platform to communicate has recently imposed a privacy policy that is unconstitutional, which not only goes against the fundamental rights of citizens but also jeopardizes the national security of our country.

RTI Activist Files a Plea in Bombay High Court Against Bharat Biotech’s Covaxin

On Saturday, a plea has been filed before the Bombay High Court by an activist stating that Bharat Biotech Covaxin had not been granted full approval but a restricted use in clinical trials according to the Drugs Comptroller General of India. The Company's phase 3 trials are ongoing and the DGCI has not made any data available in the public domain for peer- review by independent scientists.

More Articles Like This

- Advertisement -